Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome
Following treatment, two-thirds of the cohort exhibited a greater than 50 percent reduction in seizure frequency.The post Study: Adjunctive Use of FDA-Approved CBD Formulation Reduces Seizures in Pediatric Patients With Rett Syndrome appeared first on NORML.
Comments
Post a Comment